Queen Mary’s and Royal London to be Beh�et’s disease research centre
Patients suffering a rare condition that can lead to ulcers and even strokes and arthritis may soon be diagnosed quicker and more accurately with a new research centre being set up in London’s East End.
A partnership between the University of London’s Queen Mary College and the Royal London Hospital has been named as one of three ‘centres of excellence’ in the country to receive special funding to study Beh�et’s disease.
It is getting a lion’s share of a �20 million NHS budget as the largest of the centres being set up next week to delve into the causes of rare chronic inflammatory disorder.
A team of medical researchers and doctors will be led by Farida Fortune, Professor of Medicine at Queen Mary’s and consultant at the Royal London, who said: “Becoming a ‘centre of excellence’ creates potential for improving research to find new drugs and improve patients’ care and quality of life.”
Beh�et’s is caused by disturbances in the immune system which cause long-term problems such as ulcers, eye inflammation, strokes and arthritis.
You may also want to watch:
Patients have had to put up with different refferals for treatment, often with incorrect diagnosis and inadequate therapies.
Now research under one roof for all symptoms of the condition will mean quicker diagnosis and holistic treatment.
- 1 Teenager found dead in Victoria Park
- 2 Driver arrested after police 'drugs patrol' stops car in Whitechapel
- 3 Two in five people in Tower Hamlets may have had Covid-19
- 4 Post deliveries in east London hit by Covid crisis among Royal Mail staff
- 5 Drug and alcohol abuse by Tower Hamlets parents and children soars
- 6 Disgraceful management of the pandemic
- 7 'I can save the planet with my seaweed' scientist in east London claims
- 8 Leyton Orient boss Embleton expecting more movement in the transfer window
- 9 Leyton Orient sign Dan Kemp on a permanent deal from West Ham United
- 10 Leyton Orient seal late victory over Morecambe
The Whitechapel centre is joined by two others at Birmingham and Aintree being set up which will attract a combined budget of �20m over five years for diagnosis and treatment.